Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (1900)	9/26/2007 4:20:45 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

Steve, I played with LMRA last Yr during its Oct-Nov run. At that time what caused the spike was its presentation at the Westergaard SmallCap conference & the announcement of the successful testing of its millimeter wave wireless bridge, which is able to transmit vast amounts of data by a variety of high speed telecommunications networks. bigcharts.marketwatch.com But my interest on it was more because of its NanoCaptur arrays and ProteomicProcessor, since I have one of my son in laws doing some work in that field. There is a good amount of interest & competition with several companies involved,many of them in this list: functionalgenomics.org.uk LMRA in July formed a wholly owned subsidiary, Plexera Bioscience,which is where it transfered the operations of its bioscience business and is led by Joseph Vallner, Ph.D, which was before at CEGE & years ago at Syntex & GD Searle. Leroy Hood, M.D., Ph.D., president and co-founder of Institute for Systems Biology, & Josh LaBaer, M.D., Ph.D., founder and director of the Institute of Proteomics at Harvard Medical School, joined LMRA's Scientific Advisory Board in April 2006. ir.lumera.com I sold most of my shares at $10, but still have a small token position.<g> Bernard

To: Steve Lokness who wrote (1900)	2/8/2008 12:07:08 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

LMNX opened with an UG & was up 14.62% at its intraday H. It still is up 9.49% on volume of 483,578 which is close to 2x its ADV. bigcharts.marketwatch.com It announced today that it will host Planet xMAP USA 2008, the annual North American multiplexing technology symposium, on March 3-5, in Boston. This 5th annual symposium will bring together scientists working on its xMAP technology platform. The keynote presentations will be from Dr. Kathi Kellar of the CDC & microRNA pioneer Dr. Carlo Croce from Ohio State Univ. LMNX traded for a while above its Jan 24 H of $18.45 It has 4Qs of double digit improvements on revenues & the EE for 2008 are around $0.10/shr vs the loss of $0.08/shr in 2007. For 2009 a further improvement to $0.30/shr is expected. On Jan 3 it announced that it had received 510(k) clearance from the FDA for its xTAG Respiratory Viral Panel, which can simultaneously detect 12 viruses and viral subtypes responsible for more than 85% of respiratory viral infections. LMNX doesn't have significant LTD, it trads around 11xBV; has +CF; the sort ratio went up about 3% in the last month & still is around 16x its ADV. It seems that on a close above $20 the momentum could take it to test the resistance at the $30 level.<g> bigcharts.marketwatch.com Bernard